Medicines and Healthcare products Regulatory Agency
Featured
Press release
UK regulator brings new AI and MedTech agenda to AdvaMed
UK’s Medicines and Healthcare products Regulatory Agency (MHRA) sets out its next phase of MedTech and AI regulation to US industry leaders at AdvaMed 2026.
Press release
MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 October 2026, authorised plozasiran (Redemplo)
Press release
MHRA consults on proposals to allow schools to keep spare adrenaline nasal sprays on site
The MHRA is now consulting on proposals that would give schools an additional option to support children at risk of life-threatening allergic reactions.
Press release
Counterfeit weight loss pens worth £2 million seized by MHRA and West Midlands Police
Fake weight loss medicines worth approximately £2 million were seized last night in a raid executed by the Medicines and Healthcare products Regulatory Agency (MHRA) and West Midlands Police.
Press release
MHRA introduces new safeguards to strengthen antidepressant safety information following major review
New and updated patient information for antidepressant medicines to be introduced following an extensive review involving patients, families and independent experts.
Press release
MHRA 2030 Strategy to modernise patient-centred regulation for the era of AI and personalised medicines
The Medicines and Healthcare products Regulatory Agency (MHRA) has set out ambitious plans to translate cutting-edge scientific and technological innovation into better health outcomes for patients across all four nations of the UK, in its 2030 Strategy published today.
Our management
